Integral Derivatives’s Mandiant, Inc. Common Stock MNDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-22,976
Closed -$370K 1097
2017
Q4
$326K Buy
22,976
+2,065
+10% +$31.4K 0.01% 848
2017
Q3
$351K Buy
+20,911
New +$321K 0.01% 849
2017
Q2
Sell
-12,519
Closed -$178K 1332
2017
Q1
$158K Sell
12,519
-25,300
-67% -$302K ﹤0.01% 1050
2016
Q4
$450K Buy
37,819
+25,950
+219% +$337K 0.01% 754
2016
Q3
$175K Buy
+11,869
New +$182K ﹤0.01% 910
2015
Q3
Sell
-36,829
Closed -$1.54M 1292
2015
Q2
$1.8M Buy
+36,829
New +$1.67M 0.05% 348

Other funds holding MNDT

Integral Derivatives's MNDT Position: Q1 2018 in Review

Integral Derivatives sold out of Mandiant, Inc. Common Stock (MNDT) in Q1 2018, closing a stake of 22,976 shares — an estimated $370K sold.

Integral Derivatives first reported a position in MNDT in Q2 2015 and held it in 6 quarters. The position peaked at $1.8M in Q2 2015. 307 funds tracked by Wall St. Rank hold MNDT as of Q1 2018.

  • Integral Derivatives reported no remaining Mandiant, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Integral Derivatives sold 22,976 Mandiant, Inc. Common Stock shares in Q1 2018, an estimated $370K.
  • Integral Derivatives first reported a position in Mandiant, Inc. Common Stock in Q2 2015 and held it in 6 quarters.
  • Integral Derivatives's Mandiant, Inc. Common Stock position peaked at $1.8M in Q2 2015.
  • 307 funds tracked by Wall St. Rank held Mandiant, Inc. Common Stock as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.